BR112021005425A2 - polissacarídeos capsulares purificados de streptococcus pneumoniae - Google Patents
polissacarídeos capsulares purificados de streptococcus pneumoniae Download PDFInfo
- Publication number
- BR112021005425A2 BR112021005425A2 BR112021005425-1A BR112021005425A BR112021005425A2 BR 112021005425 A2 BR112021005425 A2 BR 112021005425A2 BR 112021005425 A BR112021005425 A BR 112021005425A BR 112021005425 A2 BR112021005425 A2 BR 112021005425A2
- Authority
- BR
- Brazil
- Prior art keywords
- kda
- polysaccharide
- protein
- streptococcus pneumoniae
- pneumococcal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Sustainable Development (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841031654 | 2018-09-23 | ||
| IN201841031653 | 2018-09-23 | ||
| IN201841031653 | 2018-09-23 | ||
| IN201841031654 | 2018-09-23 | ||
| PCT/IB2019/058036 WO2020058963A1 (en) | 2018-09-23 | 2019-09-23 | Purified capsular polysaccharides of streptococcus pneumoniae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021005425A2 true BR112021005425A2 (pt) | 2021-06-15 |
Family
ID=69886702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021005425-1A BR112021005425A2 (pt) | 2018-09-23 | 2019-09-23 | polissacarídeos capsulares purificados de streptococcus pneumoniae |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12048739B2 (https=) |
| EP (1) | EP3852795A4 (https=) |
| JP (2) | JP2022513562A (https=) |
| KR (1) | KR102879391B1 (https=) |
| CN (1) | CN113164581A (https=) |
| AU (1) | AU2019341723C1 (https=) |
| BR (1) | BR112021005425A2 (https=) |
| MX (1) | MX2021003358A (https=) |
| MY (1) | MY206212A (https=) |
| PH (1) | PH12021550539A1 (https=) |
| WO (1) | WO2020058963A1 (https=) |
| ZA (1) | ZA202101663B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| ES3058336T3 (es) | 2017-12-06 | 2026-03-10 | Merck Sharp & Dohme Llc | Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos |
| CR20210333A (es) | 2018-12-19 | 2021-08-18 | Merck Sharp & Dohme | Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso |
| KR20220017996A (ko) * | 2019-06-05 | 2022-02-14 | 머크 샤프 앤드 돔 코포레이션 | 면역원성 혈청형 35b 폐렴구균 폴리사카라이드-단백질 접합체 및 그를 제조하기 위한 접합 방법 |
| MY207887A (en) * | 2020-05-01 | 2025-03-26 | Sinocelltech Ltd | Method for improving immunogenicity of protein/peptide antigen |
| WO2022084852A1 (en) * | 2020-10-22 | 2022-04-28 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
| CA3200602A1 (en) * | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| EP4288106A4 (en) * | 2021-02-04 | 2025-06-04 | Merck Sharp & Dohme LLC | Lipid DNANOparticle adjuvant composition for pneumococcal conjugate vaccines |
| WO2024062494A1 (en) * | 2022-09-19 | 2024-03-28 | Biological E Limited | Method for the purification of capsular polysaccharides |
| CN117512031B (zh) * | 2023-10-16 | 2024-06-25 | 江苏金迪克生物技术股份有限公司 | 一种肺炎球菌荚膜多糖的纯化方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0027888B1 (en) | 1979-09-21 | 1986-04-16 | Hitachi, Ltd. | Semiconductor switch |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| ES2204900T3 (es) | 1992-02-11 | 2004-05-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Estructura inmuinogena de doble vector. |
| ATE280235T1 (de) | 1993-03-05 | 2004-11-15 | Wyeth Corp | Plasmid zur herstellung von crm-protein und diphtherie-toxin |
| WO1995008348A1 (en) | 1993-09-22 | 1995-03-30 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| NZ304715A (en) | 1995-03-22 | 1999-07-29 | Jackson H M Found Military Med | Production of immunogenic constructs using organic cyanylating reagents to activate carbohydrates and then coupling the carbohydrate to a protein, peptide or hapten |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| JP6502262B2 (ja) * | 2012-12-20 | 2019-04-17 | ファイザー・インク | 糖複合化方法 |
| PL3096786T3 (pl) * | 2014-01-21 | 2021-11-08 | Pfizer Inc. | Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty |
| CN110859957B (zh) | 2014-01-21 | 2024-04-12 | 辉瑞公司 | 包含缀合荚膜糖抗原的免疫原性组合物及其用途 |
| CA2968491C (en) | 2014-11-20 | 2023-09-26 | Biological E Limited | Codon optimized polynucleotide for high level expression of crm197 |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| EP3374376B1 (en) | 2015-11-09 | 2020-03-18 | Biological E Limited | Industrially scalable process for recovering biologically active recombinant carrier proteins |
| EP3436061A4 (en) * | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide-conjugate compositions and methods of use thereof |
| NZ752348A (en) * | 2016-09-30 | 2022-11-25 | Biological E Ltd | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| CN110366428B (zh) * | 2016-12-30 | 2024-05-17 | Vaxcyte公司 | 具有非天然氨基酸的多肽-抗原缀合物 |
| JP7680185B2 (ja) * | 2017-02-24 | 2025-05-20 | メルク・シャープ・アンド・ドーム・エルエルシー | 肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強 |
| SMT202200356T1 (it) | 2017-04-22 | 2022-11-18 | Biological E Ltd | Un metodo migliorato per produzione ad alto livello di crm |
| WO2019050814A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER |
| MX394767B (es) | 2017-09-07 | 2025-03-24 | Merck Sharp & Dohme Llc | Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora. |
| CN111093650B (zh) | 2017-09-07 | 2024-03-01 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
-
2019
- 2019-09-23 MX MX2021003358A patent/MX2021003358A/es unknown
- 2019-09-23 KR KR1020217011738A patent/KR102879391B1/ko active Active
- 2019-09-23 WO PCT/IB2019/058036 patent/WO2020058963A1/en not_active Ceased
- 2019-09-23 BR BR112021005425-1A patent/BR112021005425A2/pt unknown
- 2019-09-23 MY MYPI2021001583A patent/MY206212A/en unknown
- 2019-09-23 CN CN201980076246.8A patent/CN113164581A/zh active Pending
- 2019-09-23 US US17/278,181 patent/US12048739B2/en active Active
- 2019-09-23 AU AU2019341723A patent/AU2019341723C1/en active Active
- 2019-09-23 EP EP19861817.5A patent/EP3852795A4/en not_active Withdrawn
- 2019-09-23 JP JP2021516582A patent/JP2022513562A/ja not_active Withdrawn
-
2021
- 2021-03-11 ZA ZA2021/01663A patent/ZA202101663B/en unknown
- 2021-03-11 PH PH12021550539A patent/PH12021550539A1/en unknown
-
2024
- 2024-06-12 US US18/741,232 patent/US12465632B2/en active Active
- 2024-08-07 JP JP2024130732A patent/JP2024160305A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020058963A1 (en) | 2020-03-26 |
| KR20210062669A (ko) | 2021-05-31 |
| AU2019341723B2 (en) | 2024-03-21 |
| US20240325516A1 (en) | 2024-10-03 |
| EP3852795A4 (en) | 2022-11-23 |
| ZA202101663B (en) | 2024-08-28 |
| CN113164581A (zh) | 2021-07-23 |
| US20210346488A1 (en) | 2021-11-11 |
| MX2021003358A (es) | 2021-05-27 |
| KR102879391B1 (ko) | 2025-10-30 |
| US12465632B2 (en) | 2025-11-11 |
| JP2022513562A (ja) | 2022-02-09 |
| PH12021550539A1 (en) | 2022-02-21 |
| AU2019341723A1 (en) | 2021-05-20 |
| JP2024160305A (ja) | 2024-11-13 |
| US12048739B2 (en) | 2024-07-30 |
| MY206212A (en) | 2024-12-04 |
| AU2019341723C1 (en) | 2026-01-22 |
| EP3852795A1 (en) | 2021-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7403576B2 (ja) | 多糖類－タンパク質コンジュゲートを含む多価肺炎球菌ワクチン組成物 | |
| US12465632B2 (en) | Purified capsular polysaccharides of Streptococcus pneumoniae | |
| JP2020533299A (ja) | キャリアタンパク質へのコンジュゲーションのための肺炎球菌多糖の製剤方法 | |
| JP2020533439A (ja) | 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用 | |
| RS67586B1 (sr) | Formulacije pneumokoknih konjugovanih vakcina | |
| BR112021012521A2 (pt) | Vacina conjugada de polissacarídeo-proteína pneumocócica multivalente | |
| CN114025784A (zh) | 用针对肺炎链球菌血清型29进行保护的免疫原性组合物治疗患者的方法 | |
| US20230101892A1 (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates | |
| WO2020152706A1 (en) | Multivalent pneumococcal conjugate vaccine compositions | |
| EA048093B1 (ru) | Очищенные капсульные полисахариды streptococcus pneumoniae | |
| OA20178A (en) | Purified capsular polysaccharides of streptococcus pneumoniae. | |
| EA047156B1 (ru) | Мультивалентная вакцина на основе конъюгата пневмококковый полисахарид-белок | |
| EA048146B1 (ru) | Композиции поливалентной пневмококковой вакцины, содержащие конъюгаты полисахарид-белок | |
| EA040051B1 (ru) | Композиции поливалентной пневмококковой вакцины, содержащие конъюгаты полисахарид-белок | |
| OA20315A (en) | Multivalent pneumococcal polysaccharide-protein conjugate vaccine. | |
| HK40050226B (zh) | 多价肺炎球菌多糖-蛋白缀合的疫苗 | |
| BR122025016804A2 (pt) | Composição de vacina conjugada pneumocócica multivalente (pcv) e formulação de vacina conjugada pneumocócica líquida estéril 14 valente | |
| OA19223A (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharideprotein conjugates. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |